Invitation to Investor Day in Crawley, UK, March 12

lekta will publish its 9 month report on March 10 at around 13.00 CET followed by a teleconference at 15.00 CET on the same day. On March 12, Elekta will arrange an Investor Day at the company’s Product Supply Center Oncology in Crawley, UK, (close to Gatwick Airport).

Crawley United Kingdom — Sunday, January 27, 2008

We welcome private and institutional investors, buy- and sell-side analysts as well as media representatives.

To participate, please give notice to ir@elekta.com, including if you are planning to use any of the ground transports offered.

Date:
Wednesday March 12, 2008

Time:
The program will start at 11.00 BST and continue until approx. 16.30.

Location:
Elekta Limited, Linac House, Fleming Way, Crawley, West Sussex

Topics:

  • 9 months result and full year outlook
  • Status of sourcing cost reduction programs
  • Market and competitive development
  • Clinical experience of VMAT treatments
  • Live demo of VMAT and other advanced treatment techniques
  • Elekta’s strategy and roadmap in treatment planning
  • Factory tour


Presenters:

  • Tomas Puusepp, President & CEO
  • Håkan Bergström, CFO
  • Johan Sedihn, Executive VP Operations
  • James P. Hoey, Executive VP Product Creation
  • Dee Mathieson, Business Area Manager Oncology
  • Representative from Elekta’s clinical collaboration hospitals


Transport:
From London we recommend the Gatwick Express to Gatwick (30 min) and a 10 min taxi ride to Crawley
From Stockholm, we recommend:
Sterling to Gatwick (requires sleep-over):
Mar 11: dep from ARN 16:25, arr LGW 18:10
Mar 12: dep from LGW 18:40, arr ARN 22:10
Or to fly with BA to Heathrow:
Mar 12: BA0771, dep from ARN 07:00, arr LHR 09:00
Mar 12: BA0786, dep from LHR 20:10, arr ARN 23:40

Ground transport will be provided:

  • from LHR Wednesday morning after the arrival of BA0771
  • to LHR and LGW at 16.30


Hotel:
If required, we recommend:
Crowne Plaza Hotel – Gatwick
Langley Drive, Crawley, West Sussex, RH11 7SX
tel: +44 1293 608608
(5 minute taxi ride or a 20 minute walk to Elekta)
For Elekta corporate rate, please make reservation through ir@elekta.com

Warm welcome,

Peter Ejemyr
Group VP Corporate Communications

 

###

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible today.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb.

Visit Elekta - www.elekta.com

Press Releases

For further information, please contact

Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37
Email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447
Email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight Time